Zusammenfassung
Zu den Hauptursachen von Riechstörungen zählen die chronische Rhinosinusitis, das Schädel-Hirn-Trauma, die akute Infektion des oberen Respirationstrakts und neurodegenerative Erkrankungen. Riechstörungen können das Leben stark beeinträchtigen. Obwohl eine Reihe von Ansätzen zur Therapie existieren, sind unbedingt verblindete Vergleichsprüfungen zur Abgrenzung gegen die Spontanremission von Riechstörungen vor einer Therapieempfehlung zu fordern. Bei der Therapie kommt den antientzündlichen Maßnahmen sowie regenerativen Fähigkeiten des olfaktorischen Epithels besondere Bedeutung zu.
Abstract
Among the main causes of olfactory disorders are chronic rhinosinusitis, head trauma, acute infections of the upper respiratory tract and neurodegenerative diseases. Olfactory disorders can impose major restrictions on our lives. Although there are numerous approaches for the therapy of olfactory disorders, double-blind comparison studies are needed to distinguish between the effects of these therapies and spontaneous remission of olfactory disorders. The most significant aspects of treatments seem to be anti-inflammatory measures and the regenerative capabilities of the olfactory neuroepithelium.
Literatur
Doty RL, Mishra A (2001) Olfaction and its alteration by nasal obstruction, rhinitis, and rhinosinusitis. Laryngoscope 111:409–423
Pfaar O, Hüttenbrink KB, Hummel T (2004) Assessment of olfactory function after septoplasty: a longitudinal study. Rhinology 42:195–199
Pade J, Hummel T (2008) Olfactory function following nasal surgery. Laryngoscope 118:1260–1264
Guilemany JM, García-Piñero A, Alobid I et al (2009) Persistent allergic rhinitis has a moderate impact on the sense of smell, depending on both nasal congestion and inflammation. Laryngoscope 119:233–238
Becker S, Pflugbeil C, Gröger M et al (2012) Olfactory dysfunction in seasonal and perennial allergic rhinitis. Acta Otolaryngol 132:763–768
Guilemany JM, García-Piñero A, Alobid I et al (2012) The loss of smell in persistent allergic rhinitis is improved by levocetirizine due to reduction of nasal inflammation but not nasal congestion (the CIRANO study). Int Arch Allergy Immunol 158:184–190
Sivam A, Jeswani S, Reder L et al (2010) Olfactory cleft inflammation is present in seasonal allergic rhinitis and is reduced with intranasal steroids. Am J Rhinol Allergy 24:286–290
Stuck BA, Blum A, Hagner AE et al (2003) Mometasone furoate nasal spray improves olfactory performance in seasonal allergic rhinitis. Allergy 58:1195
Meltzer EO, Jalowayski AA, Orgel A, Harris AG (1998) Subjecive and objective assessments in patients with seasonal allergic rhinitis: effects of therapy with mometasone furoate nasal spray. J Allergy Clin Immunol 102:39–49
Stuck BA, Bachert C, Federspil P et al (2012) Leitlinie „Rhinosinusitis“ – Langfassung S2-Leitlinie der Deutschen Gesellschaft für Hals-Nasen-Ohren-Heilkunde, Kopf- und Hals-Chirurgie. HNO 60:141–162
Litvack JR, Mace JC, Smith TL (2009) Olfactory function and disease severity in chronic rhinosinusitis. Am J Rhinol Allergy 23:139–144
Olsson P, Stjärne P (2010) Endoscopic sinus surgery improves olfaction in nasal polyposis, a multi-center study. Rhinology 48:150–155
DeConde AS, Mace JC, Alt JA et al (2014) Comparative effectiveness of medical and surgical therapy on olfaction in chronic rhinosinusitis: a prospective, multi-institutional study. Int Forum Allergy Rhinol: 12. Juli 2014 (Epub ahead of print)
Blomqvist EH, Lundblad L, Anggard A et al (2001) A randomized controlled study evaluating medical treatment versus surgical treatment in addition to medical treatment of nasal polyposis. J Allergy Clin Immunol 107:224–228
Rombaux P, Mouraux A, Bertrand B et al (2006) Retronasal and orthonasal olfactory function in relation to olfactory bulb volume in patients with posttraumatic loss of smell. Laryngoscope 116:901–905
Yamagishi M, Fujiwara M, Nakamura H (1994) Olfactory mucosal findings and clinical course in patients with olfactory disorders following upper respiratory viral infection. Rhinology 32:113–118
Reden J, Mueller A, Mueller C et al (2006) Recovery of olfactory function following closed head injury or infections of the upper respiratory tract. Arch Otolaryngol Head Neck Surg 132:265–269
Rombaux P, Huart C, Deggouj N et al (2012) Prognostic value of olfactory bulb volume measurement for recovery in postinfectious and posttraumatic olfactory loss. Otolaryngol Head Neck Surg 147:1136–1141
Hughes LF, McAsey ME, Donathan CL et al (2002) Effects of hormone replacement therapy on olfactory sensitivity: cross-sectional and longitudinal studies. Climacteric 5:140–150
Quint C, Temmel AFP, Hummel T, Ehrenberger K (2002) The quinoxaline derivative caroverine in the treatment of sensorineural smell disorders: a proof of concept study. Acta Otolaryngol 122:877–881
Reden J, Herting B, Lill K et al (2011) Treatment of postinfectious olfactory disorders with minocycline: a double-blind, placebo-controlled study. Laryngoscope 121:679–682
Reden J, Lill K, Zahnert T et al (2012) Olfactory function in patients with postinfectious and posttraumatic smell disorders before and after treatment with vitamin A: a double-blind, placebo-controlled, randomized clinical trial. Laryngoscope 122:1906–1909
Silas J, Doty RL (2010) No evidence for specific benefit of acupuncture over vitamin B complex in treating persons with olfactory dysfunction. Otolaryngol Head Neck Surg 143:603
Silas J, Atif MA, Doty RL (2011) Transcranial magnetic stimulation: a treatment for smell and taste dysfunction. Am J Otolaryngol 32:177
Hummel T, Heilmann S, Hüttenbrink KB (2002) Lipoic acid in the treatment of smell dysfunction following viral infection of the upper respiratory tract. Laryngoscope 112:2076–2080
Henkin RI, Velicu I, Schmidt L (2009) An open-label controlled trial of theophylline for treatment of patients with hyposmia. Am J Med Sci 337:396–406
Hummel T, Rissom K, Hähner A et al (2009) Effects of olfactory training in patients with olfactory loss. Laryngoscope 119:496–499
Damm M, Pikart LK, Reimann H et al (2014) Olfactory training is helpful in postinfectious olfactory loss – a randomized controlled multicenter study. Laryngoscope 124:826–831
Haehner A, Boesveldt S, Berendse HW et al (2009) Prevalence of smell loss in Parkinson’s disease – a multicenter study. Parkinsonism Relat Disord 15:490–494
Mesholam RI, Moberg PJ, Mahr RN, Doty RL (1998) Olfaction in neurodegenerative disease: a meta-analysis of olfactory functioning in Alzheimer’s and Parkinson’s diseases. Arch Neurol 55:84–90
Conti MZ, Vicini-Chilovi B, Riva M et al (2013) Odor identification deficit predicts clinical conversion from mild cognitive impairment to dementia due to Alzheimer’s disease. Arch Clin Neuropsychol 28:391–399
Nordin S, Paulsen JS, Murphy C (1995) Sensory- and memory-mediated olfactory dysfunction in Huntington’s disease. J Int Neuropsychol Soc 1:281–290
Moscovich M, Munhoz RP, Teive HA et al (2012) Olfactory impairment in familial ataxias. J Neurol Neurosurg Psychiatry 83:970–974
Rolet A, Magnin E, Millot JL et al (2013) Olfactory dysfunction in multiple sclerosis: evidence of a decrease in different aspects of olfactory function. Eur Neurol 69:166–170
Negoias S, Croy I, Gerber J et al (2010) Reduced olfactory bulb volume and olfactory sensitivity in patients with acute major depression. Neuroscience 169:415–421
Moberg PJ, Turetsky BI (2003) Scent of a disorder: olfactory functioning in schizophrenia. Curr Psychiatry Rep 5:311–319
Haehner A, Tosch C, Wolz M et al (2013) Olfactory training in patients with Parkinson’s disease. PLoS One 8:e61680
Einhaltung ethischer Richtlinien
Interessenkonflikt. A. Hähner, T. Hummel und B.A. Stuck geben an, dass kein Interessenkonflikt besteht. Dieser Beitrag beinhaltet keine Studien an Menschen oder Tieren.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hähner, A., Hummel, T. & Stuck, B. Riechstörungen und ihre Therapie. HNO 62, 860–866 (2014). https://doi.org/10.1007/s00106-014-2924-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00106-014-2924-3